In a new study, mice whose immune systems were trained against the microbial protein flagellin did not experience the usual detrimental effects of ingesting food additive emulsifiers, pointing to a potential new way to combat various chronic inflammatory diseases.
Phathom’s first campaign for acid blocker Voquezna is the latest to use telehealth to reach potential patients directly
Phathom Pharmaceuticals today debuted its first effort for erosive esophagitis treatment Voquezna with a splashy direct-to-consumer campaign including a telehealth option. The “Kick Some Acid”
March 27, 2024